Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: In Gastric Cancer Patients with Primary Tumor Pathologic Complete Response, Treatment-Refractory Nodal Disease is an Ominous Sign

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ikoma N, Blum M, Estrella JS, et al. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer. 2018;21:74–83.

    Article  Google Scholar 

  2. Cho H, Nakamura J, Asaumi Y, et al. Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol. 2015;22:787–92.

    Article  Google Scholar 

  3. Fields RC, Strong VE, Gonen M, et al. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer. 2011;104:1840–7.

    Article  CAS  Google Scholar 

  4. Stark AP, Ikoma N, Chiang YJ, et al. Characteristics and survival of gastric cancer patients with pathologic complete response to preoperative therapy. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07638-8

    Article  PubMed  Google Scholar 

  5. Ikoma N, Estrella JS, Hofstetter W, et al. Nodal downstaging in gastric cancer patients: promising survival if ypN0 is achieved. Ann Surg Oncol. 2018;25:2012–7.

    Article  Google Scholar 

  6. Ikoma N, Hofstetter WL, Estrella JS, et al. The ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol. 2018;117:1721–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Alexander P. Stark MD, Naruhiko Ikoma MD, MS & Brian D. Badgwell MD, MS

Authors
  1. Alexander P. Stark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naruhiko Ikoma MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian D. Badgwell MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naruhiko Ikoma MD, MS.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections offer a brief invited commentary on the article, “Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy,” Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07638-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stark, A.P., Ikoma, N. & Badgwell, B.D. ASO Author Reflections: In Gastric Cancer Patients with Primary Tumor Pathologic Complete Response, Treatment-Refractory Nodal Disease is an Ominous Sign. Ann Surg Oncol 26 (Suppl 3), 819–820 (2019). https://doi.org/10.1245/s10434-019-07836-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07836-4

Search

Navigation